Suppr超能文献

与生物反馈治疗协同性排便障碍的反应相关的因素。

Factors Associated With Response to Biofeedback Therapy for Dyssynergic Defecation.

机构信息

Division of Gastroenterology and Hepatology, Department of Internal Medicine, Augusta University, Augusta, Georgia; Division of Gastroenterology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.

Division of Gastroenterology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa.

出版信息

Clin Gastroenterol Hepatol. 2018 May;16(5):715-721. doi: 10.1016/j.cgh.2017.10.027. Epub 2017 Oct 27.

Abstract

BACKGROUND & AIMS: Biofeedback therapy is effective for dyssynergic defecation (DD), but it is not widely available or reimbursed, and is labor intensive. It is therefore important to select the appropriate patients for this treatment. We investigated symptoms and demographic, manometric, and other factors associated with outcomes of biofeedback therapy in patients with DD.

METHODS

We performed a post hoc analysis of 2 prospective studies of biofeedback therapy in 127 adult outpatients (18-75 years old, 120 female) with chronic constipation who failed to respond to treatment with dietary fiber or laxatives (>1 year) and were diagnosed with DD based on standard criteria. In each study, patients received 1-hour, biweekly office biofeedback therapy (6 sessions) or home biofeedback therapy with a device. A therapist used visual feedback, postural, and diaphragmatic breathing techniques to teach subjects to improve defecation. Treatment success was defined by a composite of normalization of dyssynergia pattern and increase of 20 mm in baseline bowel satisfaction score. Factors were compared between the treatment success and failure groups. Intention-to-treat analysis was performed.

RESULTS

Of the 127 patients enrolled, 77 (61%) had treatment success. Dyssynergia was corrected in 78% of patients and bowel satisfaction improved in 64% of patients. Baseline demographic features, constipation symptoms, manometric and sensory parameters, balloon expulsion time, and colonic transit results were similar between treatment failure and success groups. Patients with lower baseline bowel satisfaction score (P = .008) and patients who used digital maneuvers (P = .04) were more likely to have successful biofeedback therapy.

CONCLUSIONS

Biofeedback therapy is successful in more than 60% of patients with DD. Patients who used digital maneuvers and patients with lower baseline levels of bowel satisfaction were more likely to have treatment success, whereas other factors were not associated with success. Biofeedback therapy should be offered to all patients with DD, irrespective of baseline symptoms or anorectal physiology findings.

摘要

背景与目的

生物反馈疗法对协同性排便障碍(DD)有效,但该疗法并未广泛应用或报销,且劳动强度大。因此,选择合适的患者接受这种治疗非常重要。我们调查了 DD 患者生物反馈治疗结局相关的症状及人口统计学、测压和其他因素。

方法

我们对 2 项生物反馈治疗前瞻性研究中的 127 例成年门诊患者(18-75 岁,120 例女性)进行了事后分析,这些患者患有慢性便秘,在膳食纤维或泻药治疗无效(>1 年)后,根据标准标准诊断为 DD。在每项研究中,患者接受 1 小时、每两周一次的办公室生物反馈治疗(6 次)或带有设备的家庭生物反馈治疗。治疗师使用视觉反馈、姿势和膈式呼吸技术来教授患者改善排便。治疗成功的定义是协同失调模式正常化和基线排便满意度评分增加 20mm 的综合指标。将治疗成功和失败组之间的因素进行比较。进行意向治疗分析。

结果

在纳入的 127 例患者中,77 例(61%)治疗成功。78%的患者协同失调得到纠正,64%的患者排便满意度提高。治疗失败和成功组之间的基线人口统计学特征、便秘症状、测压和感觉参数、球囊排出时间和结肠转运结果相似。基线排便满意度评分较低的患者(P=0.008)和使用数字手法的患者(P=0.04)更有可能接受成功的生物反馈治疗。

结论

生物反馈治疗在超过 60%的 DD 患者中取得成功。使用数字手法的患者和基线排便满意度较低的患者更有可能治疗成功,而其他因素与治疗成功无关。无论基线症状或肛门直肠生理学发现如何,都应向所有 DD 患者提供生物反馈治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验